Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.87 USD | +1.46% | -14.83% | -2.18% |
Financials (USD)
Sales 2024 * | 76.38M | Sales 2025 * | 52.83M | Capitalization | 587M |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -141M | EV / Sales 2024 * | 5.57 x |
Net cash position 2024 * | 161M | Net cash position 2025 * | 67.89M | EV / Sales 2025 * | 9.83 x |
P/E ratio 2024 * |
-4.75
x | P/E ratio 2025 * |
-4.49
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.8% |
Latest transcript on Wave Life Sciences Ltd.
1 day | +0.21% | ||
1 week | -20.00% | ||
Current month | -22.20% | ||
1 month | -15.34% | ||
3 months | +1.05% | ||
6 months | -14.59% | ||
Current year | -4.95% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Bolno
CEO | Chief Executive Officer | 50 | 13-11-30 |
Kyle Moran
DFI | Director of Finance/CFO | 54 | 14-06-30 |
Chandra Vargeese
CTO | Chief Tech/Sci/R&D Officer | 63 | 14-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
CHM | Chairman | 56 | 16-11-09 |
Mark Corrigan
BRD | Director/Board Member | 66 | 19-09-03 |
Adrian Rawcliffe
BRD | Director/Board Member | 52 | 17-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +1.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 4.94 | +2.92% | 71 251 |
24-04-18 | 4.8 | +0.21% | 538,925 |
24-04-17 | 4.79 | -8.94% | 625,510 |
24-04-16 | 5.26 | -8.36% | 528,128 |
24-04-15 | 5.74 | -1.03% | 434,701 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.95% | 587M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.75% | 21.66B | |
-18.35% | 20.77B | |
-7.45% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- WVE Stock